XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Feb. 01, 2025
Feb. 03, 2024
Jan. 28, 2023
Operating activities      
Net loss $ (154,907) $ (286,726) $ (247,422)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 20,649 15,526 11,768
Stock-based compensation expense 277,870 237,082 177,473
Net accretion of discounts on investments (15,295) (16,888) (4,368)
Lease modification, impairment, and related charges 3,529 4,762 1,056
Non-cash legal settlement 0 8,666 0
Other non-cash adjustments 1,766 4,571 6,488
Changes in operating assets and liabilities:      
Accounts receivable, net (75,531) (46,420) (47,464)
Inventories (22,416) 18,332 (7,504)
Prepaid expenses and other current assets (6,885) (29,076) (11,293)
Connected device costs (27,460) (57,893) (83,086)
Deferred commissions (31,779) (37,396) (22,409)
Other assets, non-current 4,438 509 (1,862)
Accounts payable and other liabilities 37,283 26,596 13,485
Deferred revenue 120,283 138,920 112,879
Operating lease right-of-use assets and liabilities, net 114 7,620 (762)
Net cash provided by (used in) operating activities 131,659 (11,815) (103,021)
Investing activities      
Purchases of property and equipment (20,177) (10,953) (33,240)
Purchases of investments (649,478) (740,546) (685,615)
Proceeds from sales of investments 1,247 8,168 0
Proceeds from maturities and redemptions of investments 601,987 664,694 86,625
Other investing activities (200) (50) 382
Net cash used in investing activities (66,621) (78,687) (631,848)
Financing activities      
Payment of taxes related to net share settlement of equity awards (7) 0 0
Proceeds from issuance of common stock in connection with equity compensation plans 28,799 23,202 18,047
Payment of offering costs 0 0 (2,532)
Payment of principal on finance leases (1,691) (2,205) (1,303)
Net cash provided by financing activities 27,101 20,997 14,212
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash (1,083) 477 113
Net increase (decrease) in cash, cash equivalents, and restricted cash 91,056 (69,028) (720,544)
Cash, cash equivalents, and restricted cash, beginning of period 154,738 223,766 944,310
Cash, cash equivalents, and restricted cash, end of period 245,794 154,738 223,766
Supplemental disclosure of cash flow information      
Cash paid for income taxes, net of refunds 3,463 2,122 607
Supplemental disclosures of non-cash investing and financing activities      
Property and equipment accrued but not yet paid 320 973 120
Stock option exercises in transit 0 0 2
Vesting of early exercised stock options $ 0 $ 25 $ 328